Terms: = Testicular cancer AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF AND Prognosis
10 results:
1. Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against testicular Germ Cell Tumors.
Schepisi G; Gianni C; Cursano MC; Gallà V; Menna C; Casadei C; Bleve S; Lolli C; Martinelli G; Rosti G; De Giorgi U
Front Immunol; 2023; 14():1118610. PubMed ID: 36860862
[TBL] [Abstract] [Full Text] [Related]
2. Disease Characteristics and Treatment Outcome of testicular Germ Cell Tumors Treated with Platinum-Based Regimens.
Sattar A; Masood M; Nisar H; Fatima I; Shahid AB
J Coll Physicians Surg Pak; 2018 Apr; 28(4):292-296. PubMed ID: 29615170
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance-A systematic review.
Zengerling F; Kunath F; Jensen K; Ruf C; Schmidt S; Spek A
Urol Oncol; 2018 Oct; 36(10):448-458. PubMed ID: 28712790
[TBL] [Abstract] [Full Text] [Related]
4. Patients with non-seminoma germ cell tumours treated in a minor oncology department: the importance of multi-institutional protocols and research collaboration.
Kildahl-Andersen A; Erke MG; Sagstuen H; Bremnes RM
Acta Oncol; 2005; 44(6):537-44. PubMed ID: 16165912
[TBL] [Abstract] [Full Text] [Related]
5. Reproductive technologies 1998: options available for the cancer patient.
Pfeifer SM; Coutifaris C
Med Pediatr Oncol; 1999 Jul; 33(1):34-40. PubMed ID: 10401495
[TBL] [Abstract] [Full Text] [Related]
6. The molecular basis and clinical aspects of Peutz-Jeghers syndrome.
Hemminki A
Cell Mol Life Sci; 1999 May; 55(5):735-50. PubMed ID: 10379360
[TBL] [Abstract] [Full Text] [Related]
7. Pharmacoeconomic evaluation of high-dose chemotherapy and peripheral blood stem cell support in high-risk or poor-prognosis malignancies.
Kath R; Hartmann M; Höffken K
J Cancer Res Clin Oncol; 1998; 124(5):288-90. PubMed ID: 9645462
[TBL] [Abstract] [Full Text] [Related]
8. Late relapse of germ cell tumors after cisplatin-based chemotherapy.
Gerl A; Clemm C; Schmeller N; Hentrich M; Lamerz R; Wilmanns W
Ann Oncol; 1997 Jan; 8(1):41-7. PubMed ID: 9093706
[TBL] [Abstract] [Full Text] [Related]
9. [Sequential combination chemotherapy with vinblastine/bleomycin and adriamycin/cis-dichlorodiammineplatinum (II) in non-seminomatous testicular cancer. II. Long-term results of a study with 140 patients with retroperitoneal disease (stage II) (author's transl)].
Scheulen ME; Bierbaum W; Niederle N; Eickenberg HU; Holfeld H; Seeber S; Schmidt CG
Klin Wochenschr; 1980 Aug; 58(16):823-8. PubMed ID: 6161274
[TBL] [Abstract] [Full Text] [Related]
10. [Current treatment of testicular cancers].
Amiel JL; Cukier J; Vacant J; Beurton D; Lemaire P; Rouesse J; Droz JP
Nouv Presse Med; 1976 Dec; 5(43):2929-32. PubMed ID: 1034291
[TBL] [Abstract] [Full Text] [Related]
